NATALIE BRENNINGMEYER: Open Payments
NPI 1851544167 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 11 payments from 5 companies in 2025. Trend: 2023 $1,026 · 2024 $291 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $162 |
| Astellas Pharma US Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $33 |
| ABBVIE INC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: MYFEMBREE, Veozah, ZEPBOUND, QULIPTA, Mirena.
Industry payments across KY — which companies pay providers there.
